Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2009
11/05/2009CA2725430A1 Swollenin compositions and methods of increasing the efficiency of a cellulase
11/05/2009CA2725128A1 Neurotrophic factor manf and uses thereof
11/05/2009CA2724510A1 Processes for refolding of insulin
11/05/2009CA2723449A1 Methods and compositions for modulating angiogenesis and pericyte composition
11/05/2009CA2723277A1 Improved fibronectin-based binding molecules and uses thereof
11/05/2009CA2723188A1 Armyworm insect resistance management in transgenic plants
11/05/2009CA2723169A1 Substances and compositions for enhancing dna repair and methods of use
11/05/2009CA2723095A1 Use of rice polypeptides/nucleic acids for plant improvement
11/05/2009CA2722994A1 Isolated peptides having phospholipase inhibitory activity
11/05/2009CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009CA2722889A1 New chimeric alpha-amylase variants
11/05/2009CA2722854A1 Restoration of estrogen receptor-.alpha. activity
11/05/2009CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009CA2722668A1 Methods for treating inflammation
11/05/2009CA2722095A1 Compositions and methods of using rna interference for control of nematodes
11/05/2009CA2630510A1 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/04/2009EP2113569A1 Recombinant adenoviral vector and methods of use
11/04/2009EP2113568A1 Knock-in mouse for modelling blockade of human TNFalpha
11/04/2009EP2113566A1 Genes from 20q13 amplicon and their uses
11/04/2009EP2113517A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
11/04/2009EP2113515A2 GalNAc specific binding molecules and uses thereof
11/04/2009EP2113514A1 Method for creating hypoallergenic glycoproteins in mutated or genetically modified plants or plant cells and mutated or genetically modified plants and plant cells for creating hypoallergenic glycoproteins
11/04/2009EP2113513A2 Metastin derivatives and use thereof
11/04/2009EP2113512A2 Antifungal polypeptides
11/04/2009EP2113511A1 Dna vaccines for fish
11/04/2009EP2113286A1 Uses of the BNIPXL-beta in early canities
11/04/2009EP2113030A2 Genes involved in mitochondrial biogenesis
11/04/2009EP2112999A1 Non-natural recombinant gelatins with enhanced functionality
11/04/2009EP2112998A1 Rgd containing recombinant gelatin
11/04/2009EP2112997A1 Recombinant xrgd-enriched gelatins having high stability
11/04/2009EP2112996A1 Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen
11/04/2009EP2112930A2 Modulation of nkt cell activity with antigen-loaded cdid molecules
11/04/2009EP1721976B1 Modified promoter
11/04/2009EP1700913B1 Fluorescent proteins
11/04/2009EP1692180B1 Anti-il-20 antibodies and binding partners and methods of using in inflammation
11/04/2009EP1668114B1 Polypeptide display libraries and methods of making and using thereof
11/04/2009EP1633861B1 Crystalline vap-1 and uses thereof
11/04/2009EP1559721B1 Fprl1 ligands and use thereof
11/04/2009EP1558637B1 Molecular identification of bacteria of genus streptococcus and related genuses
11/04/2009EP1542716B1 Growth hormone releasing peptides
11/04/2009EP1375664B1 Method for the secretion and production of protein
11/04/2009EP1159421B1 Human suppressor of fused
11/04/2009EP1125134B1 S100 proteins and autoantibodies as serum markers for cancer
11/04/2009EP1098910B1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
11/04/2009EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009CN101573376A Selective glucagon-like-peptide-2 (GLP-2) analogues
11/03/2009US7613659 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
11/03/2009US7612442 Semiconductor device
11/03/2009US7612268 Plants and seeds of hybrid corn variety CH042217
11/03/2009US7612267 Plants and seeds of hybrid corn variety CH532435
11/03/2009US7612266 Plants and seeds of hybrid corn variety CH130744
11/03/2009US7612261 Tomato plants
11/03/2009US7612258 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof
11/03/2009US7612256 Isolated nucleic acid molecules encoding the Br2 P-glycoprotein of maize and methods of modifying growth in plants transformed therewith
11/03/2009US7612253 Controlling expression of plant growth regulators and producing disease, stress and drought resistant plants; delaying senescence, reducing stature, increasing the number of stems, or increasing biomass in a plant
11/03/2009US7612252 Using expression vector comprising nucleotide sequences coding agamous-like-42 gene sequences(AGL42) for use as tool in the regulation and/or maintenance and/or promotion of root growth and stability
11/03/2009US7612192 Neisseria genomic sequences and methods of their use
11/03/2009US7612191 Human cytokine receptor designated as Zcytor14 polypeptide; antiinflammatory agent
11/03/2009US7612188 Modified vitamin K. dependent polypeptides
11/03/2009US7612177 Protein for use in modifying abiotic stress tolerance in yeast
11/03/2009US7612176 Polymer-based sustained release device
11/03/2009US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009US7612174 Scavenger receptor
11/03/2009US7612173 Vaccine for prevention and treatment of HIV-infection
11/03/2009US7612172 Immunization; used to elicit a humoral or cellular immune response
11/03/2009US7612171 DB, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/03/2009US7612170 Co-stimulatory polypeptides
11/03/2009US7612169 Demonstrate reduced binding affinity for TNF-related apoptosis inducing ligand (TRAIL) ; bone disorders; osteoporosis, hypercalcemia, Paget's disease of bone, multiple myeloma, bone cancer and bone loss due to rheumatoid arthritis or osteomyelitis
11/03/2009US7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV
11/03/2009US7612167 Human hematopoietic growth regulatory gene product
11/03/2009US7612163 Prokineticin 2β peptide and its use
11/03/2009US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009US7612043 Integrins; interleukins; antifertility agents
11/03/2009US7612042 Using soluble isoform of estrogen receptor as heregulin inhibiting therapeutic for use in treatment and prevention of breast and prostate cancer; competitive binding; gene therapy
11/03/2009US7612040 Lefty polypeptides and derivatives thereof
11/03/2009US7612019 Bioassay; membrane proteins; fusion proteins; capable of binding c-reactive protein; flow cytometry
11/03/2009US7611909 Near infrared chemiluminescent acridinium compounds and uses thereof
11/03/2009US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009US7611893 Metal-binding therapeutic peptides
11/03/2009US7611884 Toxoplasma gondii nucleic acid molecules
11/03/2009US7611868 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system
11/03/2009US7611867 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/03/2009US7611865 Genetic engineering
11/03/2009US7611864 Proinsulin polypeptide-oligomer conjugates
11/03/2009US7611858 diagnosis of the extent of neural injury such as in traumatic brain injury (TBI), subarachnoid hemorrhage, epilepsy, stroke, and other forms of brain injury
11/03/2009US7611857 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation
11/03/2009US7611854 improve the signal-to-noise ratio of the screening/selection system; for drug screening enzyme inhibitors; genetic engineering
11/03/2009US7611853 Identifying candidate compounds as antimalarials based on the property of binding to plasmodial parasite 90 kDa heat shock; drug screening
11/03/2009US7611851 Canis sphingosine 1-phosphate receptor isoform 1
11/03/2009US7611848 Measuring the activity of recombinant GPCR-III-Delta ) depleted of the extracellular domain of the corresponding native GPCR-III, in the presence of a given compound, compared to that of the GPCR-III- Delta in the absence of the compound; psychlogical and nervous disorders; food additives
11/03/2009US7611846 Diagnostic methods involving human growth factor huXAG-1
11/03/2009US7611833 Comprising an altered MAB1, MAB2, MAB3, or OLE1 gene; evaluating a substance as a positive strand RNA antiviral agent
11/03/2009US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009US7611721 Adjuvant combination formulations
11/03/2009US7611719 Enterovirus, vaccines, medicaments and diagnostic kits
11/03/2009US7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositions
11/03/2009US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009US7611711 VEGFR-3 inhibitor materials and methods
11/03/2009US7611700 Enyme resistant stimulatory protein for use as tools in treatment and prevention of viral infections, cell proliferative and autoimmune disorders
11/03/2009US7611699 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention;